Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (51-60 of 1,356) with videos related to

Pageof 136
Sort By:
Ejhaem|July 18, 2022
A registry study of relapsed or refractory multiple myeloma pre-exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38-targeted monoclonal antibody therapy in EnglandAhmed Elsada, Amy Zalin-Miller, Craig Knott, et al.
Ejhaem|July 18, 2022
Diagnosing dehydrated hereditary stomatocytosis due to a <i>KCNN4</i> Gardos channel mutation: understanding challenges through study of a multi-generational familySasha Waldstein, Sarah Arnold-Croop, Laura Carrel, et al.
Ejhaem|July 18, 2022
Brodie's abscess in a patient presenting with postchemotherapy neutropenic sepsisLakmali Kandabadage, Eranga Perera, Priyankara Jayawardana, et al.
Ejhaem|July 18, 2022
Secondary effects after belantamab treatment: A new anti-B-cell maturation antigen monoclonal antibody for multiple myelomaSara Garrido Paniagua, Pablo Prieto Martínez, Rafael Forés Cachón, et al.
Ejhaem|July 18, 2022
Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survivalAlessandra Casonato, Eva Galletta, Federico Galvanin, et al.
Ejhaem|July 18, 2022
Lactic acidosis and hypoglycemia as markers of disease progression of multiple myeloma: A case reportCaroline Ziegler, Lev Volkov, Rémy Marnai, et al.
Ejhaem|July 18, 2022
Thrombophagocytosis by neutrophils as a spurious cause of thrombocytopeniaErica-Mari Nell, Marthinus Johannes Dicks, Monalisa Ntobongwana
Ejhaem|July 18, 2022
Dipeptidyl-peptidase 4 inhibitor increased and maintained platelet count in a patient with primary myelofibrosisShizuka Kaneko, Yoshiyuki Onda, Soichiro Sakamoto, et al.
Ejhaem|July 18, 2022
The effect of underlying inflammation on iron metabolism, cardiovascular risk and renal function in patients with type 2 diabetesFransina Ndevahoma, Bongani B Nkambule, Phiwayinkosi V Dludla, et al.
Ejhaem|July 18, 2022
Asymptomatic leishmaniasis in a patient with relapsed multiple myelomaLucia Rubio, Maria Jimenez
Pageof 136

Showing results (51-60 of 1,356) with videos related to

Sort By:
Pageof 136
Ejhaem|July 18, 2022
A registry study of relapsed or refractory multiple myeloma pre-exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38-targeted monoclonal antibody therapy in EnglandAhmed Elsada, Amy Zalin-Miller, Craig Knott, et al.
Ejhaem|July 18, 2022
Diagnosing dehydrated hereditary stomatocytosis due to a <i>KCNN4</i> Gardos channel mutation: understanding challenges through study of a multi-generational familySasha Waldstein, Sarah Arnold-Croop, Laura Carrel, et al.
Ejhaem|July 18, 2022
Brodie's abscess in a patient presenting with postchemotherapy neutropenic sepsisLakmali Kandabadage, Eranga Perera, Priyankara Jayawardana, et al.
Ejhaem|July 18, 2022
Secondary effects after belantamab treatment: A new anti-B-cell maturation antigen monoclonal antibody for multiple myelomaSara Garrido Paniagua, Pablo Prieto Martínez, Rafael Forés Cachón, et al.
Ejhaem|July 18, 2022
Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survivalAlessandra Casonato, Eva Galletta, Federico Galvanin, et al.
Ejhaem|July 18, 2022
Lactic acidosis and hypoglycemia as markers of disease progression of multiple myeloma: A case reportCaroline Ziegler, Lev Volkov, Rémy Marnai, et al.
Ejhaem|July 18, 2022
Thrombophagocytosis by neutrophils as a spurious cause of thrombocytopeniaErica-Mari Nell, Marthinus Johannes Dicks, Monalisa Ntobongwana
Ejhaem|July 18, 2022
Dipeptidyl-peptidase 4 inhibitor increased and maintained platelet count in a patient with primary myelofibrosisShizuka Kaneko, Yoshiyuki Onda, Soichiro Sakamoto, et al.
Ejhaem|July 18, 2022
The effect of underlying inflammation on iron metabolism, cardiovascular risk and renal function in patients with type 2 diabetesFransina Ndevahoma, Bongani B Nkambule, Phiwayinkosi V Dludla, et al.
Ejhaem|July 18, 2022
Asymptomatic leishmaniasis in a patient with relapsed multiple myelomaLucia Rubio, Maria Jimenez
Pageof 136